Radiation Therapy With or Without Carbogen and Niacinamide in Treating Patients With Bladder Cancer
Status:
Completed
Trial end date:
2008-11-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. Drugs such as
carbogen and niacinamide may make tumor cells more sensitive to radiation therapy. It is not
yet known whether radiation therapy is more effective with or without carbogen and
niacinamide in treating patients who have bladder cancer.
PURPOSE: Randomized phase III trial to compare the effectiveness of radiation therapy with or
without carbogen and niacinamide in treating patients who have locally advanced bladder
cancer.
Phase:
Phase 3
Details
Lead Sponsor:
Mount Vernon Cancer Centre at Mount Vernon Hospital